Skip to main content
SMTI
NASDAQ Industrial Applications And Services

Sanara MedTech Provides FY26 Revenue Guidance and Reaffirms Strong FY25 Preliminary Results

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$20.48
Mkt Cap
$183.002M
52W Low
$18.29
52W High
$35.95
52W Position info
12% above low
Off High info
43% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

SMTI is trading near its 52-week low of $18.29 (12% above the low).

Summary

Sanara MedTech Inc. released an investor presentation outlining its strategy and providing revenue guidance of $116 million to $121 million for fiscal year 2026, alongside reaffirming its strong preliminary fiscal year 2025 results.


Key Events · Earnings and Guidance · SMTI

  • FY26 Revenue Guidance Issued

    The company projects net revenue between $116 million and $121 million for fiscal year 2026.

  • Continued Growth Anticipated

    This guidance represents a year-over-year increase of approximately 13% to 17%.

  • FY25 Preliminary Results Reaffirmed

    The company reiterated its preliminary net revenue for fiscal year 2025 at $102.7 million to $103.2 million, an increase of 19% year-over-year, consistent with the January 23, 2026 disclosure.

  • Investor Presentation Filed

    The 8-K includes an investor presentation to be used at the TD Cowen 46th Annual Health Care Conference on March 3, 2026.


Analysis · SMTI · Industrial Applications And Services

This 8-K, filed in conjunction with an investor presentation for an upcoming conference, provides crucial forward-looking information for Sanara MedTech. While the preliminary FY25 results were previously disclosed on January 23, 2026, the new fiscal year 2026 revenue guidance of $116 million to $121 million (representing 13% to 17% year-over-year growth) offers investors a clear outlook on the company's anticipated performance. This positive guidance, following strong preliminary 2025 results, suggests continued operational momentum and growth in its surgical business. Investors will likely view this as a positive signal for the company's trajectory.

How filings like this one have moved

In the 30 days to Sep 11, 2026, 30.2% of the 1943 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.21%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SMTI was trading at $20.48 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $183M. The 52-week trading range was $18.29 to $35.95. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SMTI - Latest Insights

SMTI
Sep 04, 2026, 4:08 PM EDT
Filing Type: DEFM14A
Importance Score:
8
Price at Filing: $34.72
Real-time Price: $34.92 info
Change: +$0.200 (+0.58%) info
Market Cap: $320.846M info
SMTI
Aug 11, 2026, 5:08 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $34.12
Real-time Price: $34.92 info
Change: +$0.800 (+2%) info
Market Cap: $320.846M info
SMTI
Aug 11, 2026, 4:20 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $34.12
Real-time Price: $34.92 info
Change: +$0.800 (+2%) info
Market Cap: $320.846M info
SMTI
Aug 11, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $34.12
Real-time Price: $34.92 info
Change: +$0.800 (+2%) info
Market Cap: $320.846M info
SMTI
Jul 29, 2026, 4:24 PM EDT
Filing Type: 425
Importance Score:
10
Price at Filing: $30.25
Real-time Price: $34.92 info
Change: +$4.67 (+15%) info
Market Cap: $320.846M info